Top Markets
Coin of the day
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Rang in Aktien #30249
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Aktienkurs
$1.30
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$17.66M
Veränderung (1 Tag)
3.61%
Veränderung (1 Jahr)
-17.05%
Land
FR
Handel Aelis Farma S.A. (AELIS)

Kategorie

Kursverlauf für Aelis Farma S.A. (AELIS)
Höchster Schlusskurs: $1.25 am 2026-08-01

Niedrigster Schlusskurs: $14.72 am 2022-02-01
Kursverlauf der Aktie von Aelis Farma S.A. von 2022 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 10.27%
2025 -46.69%
2024 -83.48%
2023 20.47%
2022 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$123.36 -13.14%
AU
$753.28 5.84%
CH